Cargando…

Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Wambier, Carlos Gustavo, Vaño-Galván, Sergio, McCoy, John, Pai, Suraj, Dhurat, Rachita, Goren, Andy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American Academy of Dermatology, Inc. 2020
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387285/ https://www.ncbi.nlm.nih.gov/pubmed/32735970 http://dx.doi.org/10.1016/j.jaad.2020.07.099

Ejemplares similares

Reply to comment on: The Gabrin sign
por: Wambier, Carlos Gustavo, et al.
Publicado: (2021)

Comment on: The Gabrin sign
por: Trüeb, Ralph M., et al.
Publicado: (2021)

Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
por: Wambier, Carlos Gustavo, et al.
Publicado: (2020)

Androgenetic alopecia in COVID-19: Compared to what?
por: Nanes, Benjamin A.
Publicado: (2020)

Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
por: Bukovac, Domen, et al.
Publicado: (2021)

Rational hand hygiene during the coronavirus 2019 (COVID-19) pandemic
por: Cavanagh, Gregory, et al.
Publicado: (2020)

Reply to early-onset effluvium secondary to COVID-19 and body hair effluvium
por: Wambier, Carlos Gustavo, et al.
Publicado: (2022)

Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
por: Goren, Andy, et al.
Publicado: (2021)

Response to Microneedling Treatment in Men with Androgenetic Alopecia Who Failed to Respond to Conventional Therapy
por: Dhurat, Rachita, et al.
Publicado: (2015)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
por: Dhurat, Rachita, et al.
Publicado: (2013)

Commentary
por: Shin, Daniel B., et al.
Publicado: (2021)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021)

COVID-19 compels closer scrutiny of disparities in dermatology
por: Temiz, Laurie A., et al.
Publicado: (2021)

Comment on “Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic”
por: Salman, Andac, et al.
Publicado: (2021)

Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
por: Parodi, Aurora, et al.
Publicado: (2020)

Virtual didactics exchanges to enhance trainee education
por: Shive, Melissa, et al.
Publicado: (2020)

Using cyclosporine in the COVID era: An emergent need for caution
por: Khurana, Ananta, et al.
Publicado: (2020)

Time to revisit the Health Insurance Portability and Accountability Act (HIPAA)? Accelerated telehealth adoption during the COVID-19 pandemic
por: Bhate, Chinmoy, et al.
Publicado: (2020)

Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
por: Galán, José Luis, et al.
Publicado: (2020)

Conducting inpatient dermatology consultations and maintaining resident education in the COVID-19 telemedicine era
por: Hammond, Margaret I., et al.
Publicado: (2020)

Comment on: “To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out. Characterization of herpetic lesions in hospitalized COVID-19 patients”
por: Fernandez-Nieto, Diego, et al.
Publicado: (2020)

The new normal: An approach to optimizing and combining in-person and telemedicine visits to maximize patient care
por: Cohen, Jeffrey M., et al.
Publicado: (2020)

Optimizing education for dermatology residents during the COVID-19 pandemic
por: Patel, Parth, et al.
Publicado: (2020)

Prevalence of cheilitis in health care workers treating patients with COVID-19
por: Singh, Mehak, et al.
Publicado: (2020)

The digital divide: How COVID-19's telemedicine expansion could exacerbate disparities
por: Bakhtiar, Mina, et al.
Publicado: (2020)

Caution in the time of rashes and COVID-19
por: Vesely, Matthew D., et al.
Publicado: (2020)

Dermatology in the Black barbershop: A potential opportunity for expanding access and bridging gaps
por: Okoji, Uchenna K., et al.
Publicado: (2020)

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020)

A response to “Male balding is a major risk factor for severe COVID-19”
por: Thatiparthi, Akshitha, et al.
Publicado: (2021)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

If skin is a potential host of SARS-CoV-2, IL-17 antibody could reduce the risk of COVID-19
por: Xu, Qiannan, et al.
Publicado: (2021)

In response to: “Reply to research letter”
por: Wan, Marilyn T., et al.
Publicado: (2020)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Strategies for effective medical student education in dermatology during the COVID-19 pandemic
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2021)

Expansion of asynchronous teledermatology during the COVID-19 pandemic
por: Su, Mack Y., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_65eq2ud71kvvqs0flmdrsum17t